Sputnik V is the world’s first registered vaccine based on a well-studied human adenoviral vector-based platform. Sputnik V is one of the three vaccines in the world with efficacy of over 90%. – Read More
The MoU was signed on the sidelines of the St. Petersburg International Economic Forum. Bahrain authorized the emergency use of Sputnik V In Feb. 2021.
Serbia is the European leader in vaccination with 28% of its population fully vaccinated, which is twice the European average. The use of @sputnikvaccine, with its efficiency reaching 97.6%
Human Vaccine LLC, a wholly owned subsidiary of the Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces the signing of an agreement...
The minister also revealed that the Karaganda pharmaceutical plant will produce extra 1,7 million doses of Sputnik V vaccine. They will be distributed among regions of the country according to the approved schedule.
The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) and Panacea Biotec, one of the leading vaccine and pharmaceutical producers in India, today...